Related Experiment Video
Updated: Aug 16, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD
1Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, USA.
Insights
Statin therapy for individuals over 50 with coronary artery disease and high cholesterol significantly lowers mortality and cardiovascular events. It is also beneficial for older adults without cardiovascular disease but with specific cholesterol levels.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease (CVD).
- Older adults with existing CVD or specific risk factors benefit from lipid-lowering therapies.
Purpose of the Study:
- To evaluate the efficacy of statin treatment in reducing adverse outcomes in older adults.
- To define target low-density lipoprotein (LDL) cholesterol levels for specific patient populations.
Main Methods:
- Analysis of outcomes in men and women aged 50 and older treated with statins.
- Review of LDL cholesterol targets for patients with coronary artery disease (CAD), stroke, peripheral arterial disease, or carotid arterial disease.
- Assessment of statin effectiveness in older individuals with hypercholesterolemia but no prior CVD.
Main Results:
- Statin treatment reduces all-cause mortality, cardiovascular mortality, coronary events, revascularization, stroke, and intermittent claudication in older adults with CAD and hypercholesterolemia.
- Target LDL cholesterol < 100 mg/dL is recommended for older patients with CAD, prior stroke, peripheral arterial disease, or carotid arterial disease and LDL > 125 mg/dL despite diet.
- Statins effectively reduce cardiovascular events in older persons with hypercholesterolemia but without established CVD.
Conclusions:
- Statin therapy is a cornerstone in managing hypercholesterolemia and preventing cardiovascular events in older adults.
- Specific LDL cholesterol targets should guide statin therapy initiation and titration in high-risk older populations.
- Consider statins for individuals aged 50-80 without CVD but with elevated LDL (>130 mg/dL) and low HDL (<50 mg/dL).
Abstract:
Statin treatment of men and women age > or = 50 with coronary artery disease (CAD) and hypercholesterolemia reduces the risk of all-cause mortality, cardiovascular mortality, coronary events, coronary revascularization, stroke, and intermittent claudication. The target serum low-density lipoprotein (LDL) cholesterol level is < 100 mg/dL in older patients with CAD, prior stroke, peripheral arterial disease, or extracranial carotid arterial disease and serum LDL cholesterol > 125 mg/dL despite diet therapy. Statins are also effective in reducing cardiovascular events in older persons with hypercholesterolemia but without cardiovascular disease. Consider using statins in patients age 50 to 80 without cardiovascular disease, serum LDL cholesterol > 130 mg/dL, and serum high-density lipoprotein (HDL) cholesterol < 50 mg/dL.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

